Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Escalation Study to Assess the Safety and Efficacy of SL-1002 Injectable for Treatment of Knee Pain Associated With Osteoarthritis
Conditions
Interventions
SL-1002
Placebo
Locations
15
United States
Denver Spine & Pain Institute
Greenwood Village, Colorado, United States
International Spine, Pain & Performance Center
Washington D.C., District of Columbia, United States
Prime Medical Research
Coral Gables, Florida, United States
Conquest Research
Winter Park, Florida, United States
Northwestern University
Chicago, Illinois, United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
June 13, 2022
Primary Completion Date
January 1, 2024
Completion Date
January 1, 2024
Last Updated
August 29, 2023
Lead Sponsor
Saol Therapeutics Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions